(American College of Rheumatology) The ACR has published a new white paper that provides a comprehensive overview of the scientific, clinical, economic and prescribing issues pertaining to biosimilar use. The paper encourages providers to incorporate these drugs into treatment plans of patients with rheumatic diseases.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2Bgv352
No comments:
Post a Comment